{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:10:07Z","timestamp":1780614607578,"version":"3.54.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been an alarming situation worldwide for the past 2 years. The symptoms of coronavirus disease 2019 (COVID-19) are not only confined to the respiratory system but also affect a multitude of organ systems. Bradycardia associated with Guillain-Barr\u00e9 syndrome (GBS) is a rare autonomic and peripheral neurological complication of COVID-19. In this case report, we present the case of a 26-year-old man diagnosed with bradycardia associated with GBS after contracting COVID-19. Initially, this patient had the classical symptoms of COVID-19 and was hospitalized in the intensive care unit (ICU) for acute respiratory distress syndrome (ARDS). Then, he developed weakness in the lower extremities, diminished tendon reflexes, a loss of sensation without sphincter muscle disorders, and bradycardia. His bradycardia did not respond to atropine. The patient was treated concurrently with a high-flow nasal cannula, systemic corticosteroids, anticoagulation, and therapeutic plasma exchange (TPE) for COVID-19-induced ARDS, bradycardia, and GBS. His ARDS and bradycardia improved after the first cycle of TPE and medical treatment. After three cycles of TPE, the patient progressively recovered his muscle strength in the lower limbs and regained peripheral sensation. He was discharged from the hospital in stable condition after 4 weeks of hospitalization and was followed up after 6 months for cardiorespiratory and neurological complications. This case report elucidates the potential difficulties and challenges that physicians may encounter in diagnosing and treating COVID-19-induced bradycardia and GBS during the pandemic outbreak. However, the patient outcomes with the treatment combining the conventional treatment with therapeutic plasma exchange seem to be optimistic.<\/jats:p>","DOI":"10.3389\/fcvm.2022.1035896","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:02:22Z","timestamp":1674108142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bradycardia unresponded to atropin testing was successfully treated with therapeutic plasma exchange in a patient with severe COVID-19 complicated by Guillain-Barr\u00e9 syndrome: A case report"],"prefix":"10.3389","volume":"9","author":[{"given":"Sy","family":"Duong-Quy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc","family":"Huynh-Truong-Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh","family":"Tran-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Nguyen-Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Nguyen-Thi-Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Nguyen-Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Tran-Ngoc-Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Nguyen-Van-Hoai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Do-Thi-Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram","family":"Tang-Thi-Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khue","family":"Bui-Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Hoang-Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu","family":"Nguyen-Ngoc-Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Nguyen-Nhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","article-title":"Is Guillain-Barr\u00e9 syndrome triggered by SARS-CoV-2? Case report and literature review","volume":"42","author":"Agosti","year":"2021","journal-title":"Neurol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102169","DOI":"10.1016\/j.tmaid.2021.102169","article-title":"COVID-19 infection presented as Guillain-Barr\u00e9 Syndrome: Report of two new cases and review of 116 reported cases and case series","volume":"44","author":"Elzouki","year":"2021","journal-title":"Travel Med Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13365-020-00884-7","article-title":"Severe rapidly progressive Guillain-Barr\u00e9 syndrome in the setting of acute COVID-19 disease","volume":"26","author":"Abrams","year":"2020","journal-title":"J Neurovirol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1212\/NXI.0000000000000741","article-title":"Guillain-Barr\u00e9 syndrome related to COVID-19 infection: case report","volume":"7","author":"Alberti","year":"2020","journal-title":"Journal of Neurol Neuroimmunol Neuroinflamml"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.clinph.2020.05.003","article-title":"Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome: case report","volume":"131","author":"Arnaud","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","article-title":"New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","volume":"41","author":"Assini","year":"2020","journal-title":"Neurol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1212\/NXI.0000000000000785","article-title":"Guillain-Barr\u00e9 syndrome related to SARS-CoV-2 infection","volume":"7","author":"Bigaut","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1007\/s00415-020-10014-2","article-title":"Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2","volume":"267","author":"Bracaglia","year":"2020","journal-title":"J Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2021.1886097","article-title":"A case of guillain-barr\u00e9 syndrome related to COVID-19 infection","volume":"12","author":"B\u00f6r\u00fc","year":"2021","journal-title":"Int J Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"106413","DOI":"10.1016\/j.clineuro.2020.106413","article-title":"Guillain-Barre syndrome and COVID-19: a case report","volume":"200","author":"Bueso","year":"2021","journal-title":"Clin Neurol Neurosurg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19 \u2013 associated Guillain-Barr\u00e9 syndrome: The early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.5005\/jp-journals-10071-23688","article-title":"Intravenous immunoglobulin may reverse multisystem inflammation in COVID-19 pneumonitis and Guillain-Barr\u00e9 syndrome","volume":"24","author":"Chakraborty","year":"2020","journal-title":"Indian J Crit Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1017\/cjn.2020.106","article-title":"Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection","volume":"47","author":"Chan","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1212\/CPJ.0000000000000880","article-title":"case series of Guillain barr\u00e9 syndrome following covid-19 infection in New York","volume":"11","author":"Chan","year":"2021","journal-title":"Neurol Clin Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2020.04.074","article-title":"Guillain-Barr\u00e9 syndrome as a complication of SARS-CoV-2 infection","volume":"87","author":"Coen","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.602554","article-title":"Case Report: Postacute rehabilitation of Guillain-Barr\u00e9 syndrome and cerebral vasculitis-like pattern accompanied by SARS-CoV-2 infection","author":"Colonna","year":"2021","journal-title":"Front Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajem.2020.07.074","article-title":"Guillain-Barr\u00e9 syndrome in a patient previously diagnosed with COVID-19","volume":"45","author":"Defabio","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"868667","DOI":"10.3389\/fneur.2022.868667","article-title":"Guillain-Barr\u00e9 syndrome in patient with SARS-CoV-2 PCR positivity treated successfully with therapeutic exchange plasma: a first case report from Vietnam","volume":"13","author":"Duong-Quy","year":"2022","journal-title":"Front Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"577294","DOI":"10.1016\/j.jneuroim.2020.577294","article-title":"Guillain-Barr\u00e9 syndrome in a patient infected with SARS-CoV-2, a case report","volume":"346","author":"Farzia","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e239241","DOI":"10.1136\/bcr-2020-239241","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: association or coincidence","volume":"13","author":"Gale","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nrl.2020.04.007","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"35","author":"Gal\u00e1n","year":"2020","journal-title":"Neurologia (Engl End)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e239218","DOI":"10.1136\/bcr-2020-239218","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 in Japan","volume":"13","author":"Hirayama","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: Postinfectious alone or neuroinvasive too?","volume":"93","author":"Khan","year":"2021","journal-title":"J Med Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42466-020-00066-0","article-title":"Guillain-Barr\u00e9 syndrome and SARS-CoV 2","volume":"2","author":"Lampe","year":"2020","journal-title":"Neurol Res Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan","volume":"323","author":"Wang","year":"2020","journal-title":"China JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa132","article-title":"Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series","volume":"4","author":"Peigh","year":"2020","journal-title":"Eur Heart J Case Rep."},{"key":"B29","unstructured":"COVID-19 Vaccine Janssen: Guillain-Barr\u00e9 Syndrome Listed as a Very Rare Side Effect."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.2147\/IJGM.S324349","article-title":"Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database","volume":"14","author":"Kaur","year":"2021","journal-title":"Int J Gen Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s001150170060","article-title":"Cardiac arrhythmias in Guillain-Barre syndrome. An overview of the diagnosis of a rare but potentially life-threatening complication","volume":"72","author":"Flachenecker","year":"2001","journal-title":"Nervenarzt."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.amjcard.2009.06.069","article-title":"Cardiovascular complications of the Guillain-Barr\u00e9 syndrome","volume":"104","author":"Mukerji","year":"2009","journal-title":"Am J Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/archneur.1982.00510180028007","article-title":"Complications of Plasma Exchange in Neurological Patients","volume":"39","author":"Rodnitzky","year":"1982","journal-title":"Arch Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5603\/AIT.2013.0002","article-title":"Complications in patients treated with plasmapheresis in the intensive care unit","volume":"45","author":"Szczeklik","year":"2013","journal-title":"Anaesthesiol Intensive Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12288-016-0661-3","article-title":"Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases","volume":"33","author":"Tombak","year":"2017","journal-title":"Indian J Hematol Blood Transfus."},{"key":"B36","doi-asserted-by":"publisher","first-page":"CD001798","DOI":"10.1002\/14651858.CD001798.pub2","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Raphael","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s41030-022-00188-7","article-title":"The use of therapeutic plasma exchange in the treatment of a pregnant woman with COVID-19 induced acute respiratory distress syndrome","volume":"8","author":"Duong-Quy","year":"2022","journal-title":"Pulm Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102920","DOI":"10.1016\/j.amsu.2021.102920","article-title":"Therapeutic plasma exchange in COVID-19 pnemonia in intensive care unit: Cases series","volume":"71","author":"Zaid","year":"2021","journal-title":"Ann Med Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Rumeileh","year":"2021","journal-title":"J Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma","year":"1997","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","article-title":"Treatment dilemmas in Guillain-Barr\u00e9 syndrome","volume":"88","author":"Verboon","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Wilison","year":"2016","journal-title":"Lancet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/ene.14398","article-title":"Guillain Barr\u00e9 syndrome after SARS-CoV-2 infection","volume":"27","author":"Kilinc","year":"2020","journal-title":"Eur J Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e237215","DOI":"10.1136\/bcr-2020-237215","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19 disease","volume":"13","author":"Korem","year":"2020","journal-title":"BMJ Case Rep"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1035896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:02:25Z","timestamp":1674108145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1035896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2022.1035896"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1035896","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"article-number":"1035896"}}